Evidence map›Paper›PMID 34950143›Full record

ArticleFrontiers in immunology2021

Donor T-Cell Repertoire Profiling in Recipient Lymphoid and Parenchyma Organs Reveals GVHD Pathogenesis at Clonal Levels After Bone Marrow Transplantation in Mice.

Yongxia Wu, Jianing Fu, Haizhen Wang, Xue-Zhong Yu

Open access · goldAbstract readComparative Study
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Yongxia WuDepartment of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, United States.
Jianing FuColumbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, United States.
Haizhen WangDepartment of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, United States.
Xue-Zhong YuDepartment of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, United States.
Medical University of South Carolina · USColumbia University · USMUSC Hollings Cancer Center · US

Funding

Targeting IRE-1a/XBP-1 Axis for Control of Chronic GVHD and Leukemia RelapseR01HL140953 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI YU, XUE-ZHONG · 2018 to 2021
$2.4M
MicroRNA Regulates Graft-versus-Host DiseaseR01AI118305 · NIAID · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI YU, XUE-ZHONG · 2015 to 2019
$1.7M
Separation of GVH and GVL Responses Using Alloreactive CD8 iTregsR01HL137373 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI YU, XUE-ZHONG · 2017 to 2020
$1.5M
NHLBI NIH HHS R01 HL137373NHLBI NIH HHS R01 HL140953NIAID NIH HHS R01 AI118305
6 · The paper itself

Abstract

The diversity and composition of T-cell receptor (TCR) repertoire, which is the result of V, (D), and J gene recombination in TCR gene locus, has been found to be implicated in T-cell responses in autoimmunity, cancer, and organ transplantation. The correlation of T-cell repertoire with the pathogenesis of graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplantation remains largely undefined. Here, by utilizing high-throughput sequencing of the genes encoding TCRβ-chain, we comprehensively analyzed the profile of T-cell repertoire in recipient lymphoid and GVHD target organs after bone marrow transplantation (BMT) in mice. In lymphoid organs, TCR diversity was narrowed, accompanied with reduced numbers of unique clones while increased accumulation of dominant clones in allogeneic T cells compared to syngeneic T cells. In an individual allogeneic recipient, donor-derived TCR clones were highly overlapped among tissue sites, and the degree of overlapping was increasing from day 7 to 14 after allogeneic BMT. The top clones in peripheral blood, gut, liver, and lungs were highly mutually shared in an allogenic recipient, indicating that blood has the potential to predict dominant clones in these GVHD target organs. T cells in GVHD target organs from allogeneic recipients had fewer overlapped clones with pre-transplant donor T cells compared to those from syngeneic recipients. Importantly, the top 10 clones in allogeneic recipients were not detectable in pre-transplant donor T cells, indicating clonal expansion of rare rearrangements. Interestingly, even starting from the same pool of donor repertoires, T cells had very few overlapped clones between each allogeneic recipient who developed completely different dominant clones. We were only able to trace a single clone shared by three replicate allogeneic recipients within the top 500 clones. Although dominant clones were different among allogeneic recipients, V26 genes were consistently used more frequently by TCR clones in allogeneic than syngeneic recipients. This is the first study to extensively examine the feature of T-cell repertoire in multiple lymphoid and parenchyma organs, which establishes the association between T-cell activation and GVHD pathogenesis at the level of TCR clones. Immune repertoire sequencing-based methods may represent a novel personalized strategy to guide diagnosis and therapy in GVHD.

Indexed as

Clonal Selection, Antigen-MediatedGene Expression ProfilingGenes, T-Cell Receptor betaTranscriptomeAnimalsBone Marrow TransplantationDisease Models, AnimalGraft vs Host DiseaseHigh-Throughput Nucleotide SequencingHomeodomain ProteinsLymphocyte ActivationLymphoid TissueMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutHomeodomain ProteinsRAG-1 proteinallogeneic hematopoietic stem cell transplantationbone marrow transplantationgraft-versus-host diseaseT cellsTCR repertoire

Identifiers

PMID34950143
PMCPMC8688739
OpenAlexW4200582987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.